Advertisement
For patients with transfusion-dependent β-thalassemia

Reduction Noted in Transfusion Burden With Luspatercept

0
Reduction seen with luspatercept versus placebo for patients with transfusion-dependent β-thalassemia
In the field of medical imaging

Prospective, Randomized Studies of AI Lacking in Medical Imaging

0
Many studies claiming artificial intelligence as good as humans are of poor quality, with high risk for bias
Acute kidney injury seems to promote the development of papillary renal cell carcinoma from single progenitors

Acute Kidney Injury Seems to Promote Renal Cell Carcinoma

0
AKI promotes the development of papillary renal cell carcinoma from single progenitors
Patients with cancer in Wuhan had an increased risk for severe acute respiratory syndrome-coronavirus 2 infection

Increased Risk for SARS-CoV-2 Seen in Cancer Patients in Wuhan

0
Of the 12 patients with COVID-19, six developed severe acute respiratory syndrome; three died
The National Institutes of Health has launched a new website with educational resources for hospital employees

Workers at Risk for COVID-19 Exposure Can Access Online Training

0
The National Institute of Environmental Health Sciences launched virtual training website to protect workers
National health expenditures are projected to increase at an average annual rate of 5.4 percent for 2019 to 2028

National Health Spending Expected to Increase Through 2028

0
National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
Inhibition of interleukin-1β with canakinumab is associated with reduced incident anemia as well as improved hemoglobin levels among patients with baseline anemia

Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia

0
Among those with baseline anemia, hemoglobin levels improved with canakinumab versus placebo
Insulin and other biologic drugs

FDA: Insulin Among Drugs Transitioned to Biological Products

0
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
A greater number of daily steps -- 8

More Steps in a Day Tied to Lower Risk for Death

0
Step intensity not linked to significantly lower mortality risk after adjusting for total steps per day
For men with intermediate- and high-risk prostate adenocarcinoma

10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer

0
10-year cumulative incidence of biochemical and/or clinical disease failure no different with C-, H-IMRT